Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma
Decysin-1 (ADAMDEC1) is an orphan ADAM-like metalloprotease with unknown biological function and a short domain structure. ADAMDEC1 mRNA has previously been demonstrated primarily in macrophages and mature dendritic cells. Here, we generated monoclonal antibodies (mAbs) against the mature ADAMDEC1 p...
Auteurs principaux: | Lund, J, Elimar Bitsch, A, Grønbech Rasch, M, Enoksson, M, Troeberg, L, Nagase, H, Loftager, M, Overgaard, M, Petersen, H |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Taylor and Francis
2017
|
Documents similaires
-
Evidence for Restricted Reactivity of ADAMDEC1 with Protein Substrates and Endogenous Inhibitors.
par: Lund, J, et autres
Publié: (2015) -
ADAMDEC1 accelerates GBM progression via activation of the MMP2-related pathway
par: Huimin Qi, et autres
Publié: (2022-09-01) -
ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway
par: Shuo Zhou, et autres
Publié: (2025-01-01) -
ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells
par: Ana Jimenez-Pascual, et autres
Publié: (2020-01-01) -
Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains
par: Julio Plaza-Díaz, et autres
Publié: (2017-05-01)